Comparing two diabetes medications, empagliflozin and dapagliflozin

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of empagliflozin and dapagliflozin in treating patients with type 2 diabetes, chronic kidney disease, and heart failure. Patients who are prescribed either medication as part of their routine care will be included, with treatment assignments randomized through electronic health record systems based on the time of day. This pragmatic approach allows for real-world data collection and analysis of outcomes in a clinical setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 years or more

Exclusion Criteria:

* Incapabability of giving informed consent
* Withdrawal of informed consent

Where it's running

• Bispebjerg Hospital
  Copenhagen, Denmark Recruiting
• Rigshospitalet
  Copenhagen, Denmark Recruiting
• Herlev and Gentofte Hospital
  Herlev, Denmark Recruiting
• Steno Diabetes Center Copenhagen
  Herlev, Denmark Recruiting
• Nordsjællands Hospital
  Hillerød, Denmark Recruiting
• Holbæk Sygehus
  Holbæk, Denmark Recruiting

Study contacts

• Study coordinator: Morten Schou, Professor
• Email: morten.schou.04@regionh.dk
• Phone: 004540523920

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Exploring heart failure and diabetes interactions

  This study looks at how heart failure and diabetes affect the body differently by testing 600 people with various combinations of these conditions.

  Recruiting University of Leeds · Leeds, West Yorkshire · NCT06774014

• Optimizing heart failure treatment in elderly patients with kidney issues

  This study is testing if a new medication can help older patients with heart failure and kidney problems safely take higher doses of their heart medications without raising potassium levels too much.

  Recruiting at 3 sites Phase 3 Fundación para la Investigación del Hospital Clínico de Valencia · Alcorcón, Madrid and 5 other locations · NCT06578078

• App to support post-hospital care for people with multiple chronic conditions

  This trial will test a smartphone/tablet app to help people aged 55+ with heart failure, diabetes, or chronic kidney disease manage their care after leaving the hospital.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT06051058

• Understanding challenges and support for African American adults with kidney disease and diabetes

  This study looks at the challenges and support African American adults with kidney disease and diabetes face to see how it affects their health and how to help them take better care of themselves.

  Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT05692388

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.